Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.

Clinical trial NCT00308243 · COMPLETED

Trial details

NCT number: NCT00308243
Sponsor: Emphycorp
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2006-03-01
Primary completion: 2007-03-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.